Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Gene Therapy|January 7, 2020
Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applicationsSarah L Hulin-Curtis, James A Davies, Davor Nestić, et al.
FEMS Microbiology Ecology|January 20, 2007
The GacS sensor kinase controls phenotypic reversion of small colony variants isolated from biofilms of Pseudomonas aeruginosa PA14James A Davies, Joe J Harrison, Lyriam L R Marques, et al.
The Journal of Clinical Investigation|August 4, 2010
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replicationRichard J Stanton, Katarina Baluchova, Derrick J Dargan, et al.
Neuro-Oncology|May 28, 2020
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumorsPhonphimon Wongthida, Matthew R Schuelke, Christopher B Driscoll, et al.
Elife|December 25, 2019
Human cytomegalovirus interactome analysis identifies degradation hubs, domain associations and viral protein functionsLuis V Nobre, Katie Nightingale, Benjamin J Ravenhill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2018
Ad5<sub>NULL</sub>-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer TherapiesHanni Uusi-Kerttula, James A Davies, Jill M Thompson, et al.
Molecular Therapy Oncolytics|April 11, 2022
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10Emily A Bates, James A Davies, Jana Váňová, et al.
Molecular Therapy. Methods & Clinical Development|August 29, 2024
A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applicationsCarly M Bliss, Sarah L Hulin-Curtis, Marta Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2020
Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant CellsMartin J Scurr, Alex Greenshields-Watson, Emma Campbell, et al.
Pageof 3